Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA product code OYM · Class III (high risk) · Immunology
An in vitro nucleic acid amplification test that measures the concentration of prostate cancer genes.
0510(k) clearances
1PMA approvals
0recalls
PMA approvals
- P100033 Progensa PCA3 Assay · Gen-Probe Incorporated · 02/13/2012